|
FBXO38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.315600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.952400E-02 |
| Normal-vs-Stage2 |
9.598400E-01 |
| Normal-vs-Stage3 |
8.577400E-01 |
| Normal-vs-Stage4 |
3.553000E-01 |
| Stage1-vs-Stage2 |
2.564600E-01 |
| Stage1-vs-Stage3 |
2.964200E-01 |
| Stage1-vs-Stage4 |
9.299800E-01 |
| Stage2-vs-Stage3 |
8.687200E-01 |
| Stage2-vs-Stage4 |
5.222200E-01 |
| Stage3-vs-Stage4 |
6.027800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.057900E-02 |
| Normal-vs-AfricanAmerican |
1.189630E-01 |
| Normal-vs-Asian |
7.154400E-01 |
| Caucasian-vs-AfricanAmerican |
8.891800E-01 |
| Caucasian-vs-Asian |
3.203800E-01 |
| AfricanAmerican-vs-Asian |
3.089400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.015790E-02 |
| Normal-vs-Female |
7.433000E-01 |
| Male-vs-Female |
1.388350E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.016200E-01 |
| Normal-vs-Extreme_Weight |
8.897000E-03 |
| Normal-vs-Obese |
2.434800E-01 |
| Normal-vs-Extreme_Obese |
4.965500E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.581800E-01 |
| Normal_Weight-vs-Obese |
8.348800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.025200E-01 |
| Extreme_Weight-vs-Obese |
2.864000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.841000E-01 |
| Obese-vs-Extreme_Obese |
2.458800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.619800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.218400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.595600E-03 |
| Normal-vs-Age(81-100Yrs) |
4.128400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.057600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.300800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.571800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.254000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.513600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.131800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.606290E-02 |
| Normal-VS-Type2 PRCC |
4.826600E-01 |
| Normal-VS-KIRP CIMP |
1.208050E-02 |
| Normal-VS-Unclassified PRCC |
8.731400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.315800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.650200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.605900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.538200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.329000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.576840E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.651700E-02 |
| Normal-vs-N1 |
6.307600E-01 |
| Normal-vs-N2 |
3.720800E-01 |
| N0-vs-N1 |
4.570800E-01 |
| N0-vs-N2 |
9.110200E-01 |
| N1-vs-N2 |
8.096600E-01 |
|
|
